3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Other
1
Genitourinary
1
Conditions
Eunuchism
2
Sarcopenia
1
Prostatic Neoplasms
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Metabolic Syndrome
1
Metabolic Diseases
1
Diabetes Mellitus
1
Colorectal Neoplasms
1
Cardiovascular Diseases
1
Breast Neoplasms
1
Interventions
Blood Specimen Collection
5
Surveys and Questionnaires
3
exemestane
2
Tirzepatide
2
Tamoxifen
2
Observation
2
Esophagectomy
2
Biopsy
2
BaseLine dental cement
2
Bariatric Surgery
2
Anastrozole
2
semaglutide
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Utrogestan
1
Urine Specimen Collection
1
Topiramate
1
Testosterone
1
Stents
1
Qsymia
1
Phentermine
1
Naltrexone
1
Metabolic Networks and Pathways
1
Medical History Taking
1
Mammography
1
Liraglutide
1
Letrozole
1
Hematologic Tests
1
Gonadotropin-Releasing Hormone
1
Glucose Tolerance Test
1
Glucagon-Like Peptide-1 Receptor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Obesity
×
Testosterone
×
Clear all
NCT05773183
2023-03-17
MMetdMH
Royal College of Surgeons, Ireland
Unknown
60 enrolled